Anke M Onnekink (A M Onnekink)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Cross Sectional

Coronary Artery Bypass

Top Venues

Familial cancer

The British journal of surgery

This page only lists publications with an associated author ORCID identifier.

Publications

Anke M Onnekink, D C F Klatte, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial cancer 23 (3) (2024)
Anke M Onnekink, D C F Klatte, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial cancer (2024)
Anke M Onnekink, Nynke Michiels, Derk C F Klatte, Lotte Oldenburg, J Sven D Mieog, Alexander L Vahrmeijer, Jeanin E van Hooft, Monique E van Leerdam, Bert A Bonsing
Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance. The British journal of surgery 111 (1) (2024)
Anke M Onnekink, D C F Klatte, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial cancer 23 (3) (2024)
Anke M Onnekink, D C F Klatte, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial cancer 23 (3) (2024)
Anke M Onnekink, D C F Klatte, J E van Hooft, S H van den Berg, S M S van der Zwaan, R van Doorn, S C H Hinnen, T P Potjer, E M A Bleiker, M E van Leerdam
Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant. Familial cancer 23 (3) (2024)
Anke M Onnekink, Nynke Michiels, Derk C F Klatte, Lotte Oldenburg, J Sven D Mieog, Alexander L Vahrmeijer, Jeanin E van Hooft, Monique E van Leerdam, Bert A Bonsing
Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance. The British journal of surgery (2023)